Cory A. Perugino

5.8k citations

44 papers · 2.0k indexed · 3 hit papers · h-index 21

Rheumatology top 0.5%
- IgG4-Related and Inflammatory Diseases 35
Epidemiology top 2%
- Neuroendocrine Tumor Research Advances 22
Surgery top 5%
- Gastrointestinal disorders and treatments 17
- Pancreatitis Pathology and Treatment 5
Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 3
Pathology and Forensic Medicine top 10%
- Autoimmune Bullous Skin Diseases 3
Hematology
- Platelet Disorders and Treatments 4
Infectious Diseases
- SARS-CoV-2 and COVID-19 Research 2

Co-authors: John H. Stone Zachary S. Wallace James R. Stone Hyon K. Choi Shiv Pillai Ray Naden Yuqing Zhang Hamid Mattoo
Cited by: Rheumatology Epidemiology Surgery
Partner nations: United States Japan Italy

In The Last Decade

Cory A. Perugino

41 papers receiving 1.9k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 IgG4-related disease: an update on pathophysiology and implications for clinical care
2019 Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts
2019 The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease

Peers

Countries citing papers authored by Cory A. Perugino

Since Specialization

Citations

This map shows the geographic impact of Cory A. Perugino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory A. Perugino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory A. Perugino more than expected).

Fields of papers citing papers by Cory A. Perugino

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cory A. Perugino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory A. Perugino. The network helps show where Cory A. Perugino may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cory A. Perugino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cory A. Perugino Line = papers co-authored together Cory A. Perugino links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Granzyme K T cells and hypocomplementaemia in IgG4-RD T. Sloane Guy,C.V. Gadiraju,John H. Stone,Cory A. Perugino,Vinay S. Mahajan,S. Pillai	2025	0
2	Defining pancreatic damage and symptom burden in IgG4-related autoimmune pancreatitis: A cross-sectional study of 118 patients from a single-center registry Guy Katz,Liam Harvey,Yasmin G. Hernandez‐Barco,Zachary S. Wallace,Ana D. Fernandes,Grace A. McMahon,Isha Jha,Aubree E. McMahon,Cory A. Perugino,John H. Stone	2025	0
3	Proliferative features of IgG4-related disease Guy Katz,Yasmin G. Hernandez‐Barco,Diego Palumbo,Thomas V. Guy,Lingli Dong,Cory A. Perugino	2024	14
4	Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG4-related disease: an open-label, single-arm, single centre, phase 2 pilot trial Cory A. Perugino,Zachary S. Wallace,Debra Zack,Stephanie Quinn,Allen Poma,Ana D. Fernandes,Paul Foster,Steve DeMattos,Bart Burington,Hang Liu,Hugues Allard‐Chamard,Nathan Smith,Xin Kai,Kelly Xing,Shiv Pillai,John H. Stone	2023	33
5	Assessment of patient-reported symptoms and distress in IgG4-related disease (IgG4-RD): Development, clinical validation, and content validation of the IgG4-RD Symptom Severity Index Zachary S. Wallace,Grace A. McMahon,Buuthien Hang,Xiaoqing Fu,Tyler Harkness,Karen Donelan,Ana D. Fernandes,Claire Cook,Guy Katz,Cory A. Perugino,John H. Stone	2023	3
6	Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura disease Ryusuke Munemura,Takashi Maehara,Yuka Murakami,Risako Koga,Ryuichi Aoyagi,Naoki Kaneko,Atsushi Doi,Cory A. Perugino,Emanuel Della‐Torre,Takako Saeki,Yasuharu Sato,Hidetaka Yamamoto,Tamotsu Kiyoshima,John H. Stone,Shiv Pillai,Seiji Nakamura	2022	36
7	Cytotoxic CD8+ T cells may be drivers of tissue destruction in Sjögren’s syndrome Naoki Kaneko,Hu Chen,Cory A. Perugino,Takashi Maehara,Ryusuke Munemura,Shiho Yokomizo,Junsei Sameshima,Thomas Diefenbach,Katherine R. Premo,Akira Chinju,Yuka Miyahara,M. Sakamoto,Masafumi Moriyama,John H. Stone,Seiji Nakamura,Shiv Pillai	2022	22
8	The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease Matthew Baker,Claire Cook,Xiaoqing Fu,Cory A. Perugino,John H. Stone,Zachary S. Wallace	2022	5
9	The Association of Illness-related Uncertainty With Mental Health in Systemic Autoimmune Rheumatic Diseases Zachary S. Wallace,Claire Cook,Lucy Finkelstein‐Fox,Xiaoqing Fu,Flavia V. Castelino,Hyon K. Choi,Cory A. Perugino,John H. Stone,Elyse R. Park,Daniel L. Hall	2022	10
10	Temporal changes in T cell subsets and expansion of cytotoxic CD4+ T cells in the lungs in severe COVID-19 Naoki Kaneko,Julie Boucau,Hsiao-Hsuan Kuo,Cory A. Perugino,Vinay S. Mahajan,Jocelyn R. Farmer,Hang Liu,Thomas Diefenbach,Alicja Piechocka‐Trocha,Kristina Lefteri,Michael T. Waring,Katherine R. Premo,Bruce D. Walker,Jonathan Z. Li,Gaurav D. Gaiha,Xu G. Yu,Mathias Lichterfeld,Robert F. Padera,Shiv Pillai	2022	29
11	Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis Damian R. Plichta,Juhi Somani,Matthieu Pichaud,Zachary S. Wallace,Ana D. Fernandes,Cory A. Perugino,Harri Lähdesmäki,John H. Stone,Hera Vlamakis,Daniel C. Chung,Dinesh Khanna,Shiv Pillai,Ramnik J. Xavier	2021	37
12	Neutralizing anti–IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease Justin A. Jarrell,Matthew Baker,Cory A. Perugino,Hang Liu,Michelle S. Bloom,Takashi Maehara,Heidi Wong,Tobias V. Lanz,Julia Z. Adamska,Sarah Kongpachith,Jeremy Sokolove,John H. Stone,Shiv Pillai,William H. Robinson	2021	20
13	Prostate and pancreas involvement are linked in IgG4-related disease Hang Liu,Zachary S. Wallace,Liam Harvey,Rory Crotty,Chin‐Lee Wu,Vikram Deshpande,Aileen O’Shea,Mukesh G. Harisinghani,Musie Ghebremichael,Ajay Nehra,John H. Stone,Cory A. Perugino	2020	8
14	Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis Takashi Maehara,Naoki Kaneko,Cory A. Perugino,Hamid Mattoo,Jesper Kers,Hugues Allard‐Chamard,Vinay S. Mahajan,Hang Liu,Samuel J. H. Murphy,Musie Ghebremichael,David A. Fox,Aimee Payne,Robert Lafyatis,John H. Stone,Dinesh Khanna,Shiv Pillai	2020	127
15	Disease Severity Linked to Increase in Autoantibody Diversity in IgG4‐Related Disease Hang Liu,Cory A. Perugino,Musie Ghebremichael,Zachary S. Wallace,Sydney B. Montesi,John H. Stone,Shiv Pillai	2019	46
16	Diagnostic Pitfalls in Immunology Testing Lewena Maher,Cory A. Perugino	2019	2
17	The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related diseasebreakdown → Zachary S. Wallace,Ray Naden,Suresh T. Chari,Hyon K. Choi,Emanuel Della‐Torre,Jean-Francois Dicaire,Phillip A. Hart,Dai Inoue,Mitsuhiro Kawano,Arezou Khosroshahi,Marco Lanzillotta,Kazuichi Okazaki,Cory A. Perugino,Amita Sharma,Takako Saeki,N. Schleinitz,Naoki Takahashi,Hisanori Umehara,Yoh Zen,James R. Stone	2019	409
18	Immunoglobulin G4–related Disease Zachary S. Wallace,Cory A. Perugino,Mark Matza,Vikram Deshpande,Amita Sharma,John H. Stone	2019	26
19	Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohortsbreakdown → Zachary S. Wallace,Yuqing Zhang,Cory A. Perugino,Ray Naden,Hyon K. Choi,James R. Stone	2019	238
20	Identification of galectin-3 as an autoantigen in patients with IgG4-related disease Cory A. Perugino,Sultan B. AlSalem,Hamid Mattoo,Emanuel Della‐Torre,Vinay S. Mahajan,Gayathri Ganesh,Hugues Allard‐Chamard,Zachary S. Wallace,Sydney B. Montesi,Johannes Kreuzer,Wilhelm Haas,John H. Stone,Shiv Pillai	2018	117

About Cory A. Perugino

Cory A. Perugino is a scholar working on Rheumatology, Epidemiology and Surgery, having authored 44 papers that have together received 2.0k indexed citations. Recurring topics across this work include IgG4-Related and Inflammatory Diseases (35 papers), Neuroendocrine Tumor Research Advances (22 papers), Gastrointestinal disorders and treatments (17 papers), Pancreatitis Pathology and Treatment (5 papers), Platelet Disorders and Treatments (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Autoimmune Bullous Skin Diseases (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Rheumatology (1.6k citations), Epidemiology (1.0k citations) and Surgery (1.0k citations). Cory A. Perugino has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include John H. Stone, Zachary S. Wallace, James R. Stone, Hyon K. Choi, Shiv Pillai, Ray Naden, Yuqing Zhang, Hamid Mattoo, Vinay S. Mahajan and Marco Lanzillotta.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact